Inicio > MIRAMONTES GONZALEZ, JOSE PABLO

MIRAMONTES GONZALEZ, JOSE PABLO

PROFESOR CONTRATADO DOCTOR
Medicina, Dermatología y Toxicología
 
jpmiramontes@uva.es

Índice H en Scopus: 15
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=84112]], camposKey:1876-0341 2024-06-01 COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study939946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=86559]], camposKey:2169-3536 2024-01-01 Breast carcinoma prediction through integration of machine learning models00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80375]], camposKey:2072-6694 2023-09-01 Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77449]], camposKey:1130-0108 2023-04-01 Median arcuate ligament syndrome: a rare cause of abdominal pain219220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77450]], camposKey:2617-2216 2023-03-30 Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77451]], camposKey:0014-2565 2023-03-01 Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad134143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77452]], camposKey:1130-0108 2023-02-01 DRESS syndrome secondary to carbamazepine9697, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76166]], camposKey:0026-4806 2023-02-01 High cobalamin levels as a five-year risk predictor for developing hematological cancer2228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77547]], camposKey:0014-2565 2023-01-01 Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad134143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77453]], camposKey:0300-7995 2023-01-01 Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77551]], camposKey:0211-139X 2023-01-01 RÉPLICA A «Consideraciones al manuscrito cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?»520, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77454]], camposKey:0211-139X 2023-01-01 Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?» RÉPLICA A «Consideraciones al manuscrito cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?»00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81222]], camposKey:2523-1995 2023-01-01 The relationship between PARP inhibitors with the relapse and leukemisation of lymphomas: a case report , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77455]], camposKey:1471-2318 2022-12-01 Differences in clinical features and mortality in very old unvaccinated patients (¿ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77337]], camposKey:1664-2392 2022-09-16 Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77456]], camposKey:0211-139X 2022-09-01 Cancer and elderly: Two incompatible concepts for intensive care? Cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77457]], camposKey:0025-7753 2022-07-08 Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77458]], camposKey:1664-2392 2022-06-24 Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75591]], camposKey:2077-0383 2022-06-01 Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77459]], camposKey:0002-8614 2022-05-01 Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure15851589, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77460]], camposKey:2768-6701 2022-03-01 Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77462]], camposKey:0742-3071 2022-02-01 Basal insulin analogues in people with diabetes and chronic kidney disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77461]], camposKey:2227-9059 2022-02-01 Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77541]], camposKey:0025-7753 2022-01-01 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77536]], camposKey:0211-139X 2022-01-01 Cáncer y población geriátrica:: ¿dos conceptos incompatibles para la realización de cuidados intensivos?2860, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77463]], camposKey:2075-1729 2021-12-01 Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65946]], camposKey:1076-1608 2021-12-01 Sclerodermiform Syndrome Induced by Hydroxycarbamide00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77464]], camposKey:0014-2565 2021-10-01 Porcelain aorta Aorta en porcelana00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77465]], camposKey:2076-3417 2021-09-01 The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77338]], camposKey:0014-2565 2021-05-01 Is Nutrition the Forgotten Risk Factor in COVID19 Infection?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77467]], camposKey:0014-2565 2021-05-01 Is Nutrition the Forgotten Risk Factor in COVID-19 Infection? ¿Es la nutrición el factor de riesgo olvidado en la infección por COVID-19?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77466]], camposKey:2077-0383 2021-05-01 Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77339]], camposKey:2574-0954 2021-03-01 Black esophagus and diabetes: a close relationship5961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72051]], camposKey:2218-273X 2021-02-01 Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77540]], camposKey:0014-2565 2021-01-01 Aorta en porcelana4930, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77340]], camposKey:0021-9150 2021-01-01 Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study5258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64713]], camposKey:0014-2565 2021-01-01 ¿Es la nutrición el factor de riesgo olvidado en la infección por COVID-19?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76541]], camposKey:2077-0383 2021-01-01 Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61382]], camposKey:0300-7995 2021-01-01 The nutritional status of the elderly patient infected with COVID-19: the forgotten risk factor?549554, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77341]], camposKey:0014-2565 2020-11-01 Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination511517, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77343]], camposKey:0014-2565 2020-10-01 Heart failure and diabetes, opportunities for improving treatment through patient characterisation437438, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65748]], camposKey:0300-8932 2020-10-01 Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART828834, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66396]], camposKey:0953-6205 2020-10-01 VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension6065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77342]], camposKey:0923-7534 2020-09-01 Impact of systemic treatment versus best supportive care on survival in patients older than 80 years with cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77344]], camposKey:1462-8902 2020-09-01 In response to the paper 'High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?'17011702, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77346]], camposKey:2045-2322 2020-02-14 A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function (vol 9, 5055, 2019)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77345]], camposKey:0732-183X 2020-02-10 Use of glycosylated hemoglobin and C-peptide levels in the diagnosis and prevention of type 1 diabetes mellitus as an immune-related adverse event secondary to treatment with immunotherapy in solid tumors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63235]], camposKey:1828-0447 2020-01-01 Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events15331544, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77545]], camposKey:0300-8932 2020-01-01 Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART828834, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77534]], camposKey:0014-2565 2020-01-01 Insuficiencia cardíaca y diabetes, oportunidades de mejora en el tratamiento a través de la caracterización de pacientes437438, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77347]], camposKey:0085-2538 2020-01-01 Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?213213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77544]], camposKey:0014-2565 2020-01-01 La inflamación, la desnutrición y la infección por SARS-CoV-2: una combinación nefasta511517, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77349]], camposKey:1933-2874 2019-12-01 Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study989996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77348]], camposKey:0168-8227 2019-12-01 Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77353]], camposKey:0021-9541 2019-07-01 In response to Yaribeygi et al. "Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"99069907, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77350]], camposKey:0014-2565 2019-05-01 Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77352]], camposKey:2213-8587 2019-05-01 GLP-1 and the renin-angiotensin-aldosterone system337337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77351]], camposKey:2045-2322 2019-03-25 A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77354]], camposKey:0168-8227 2019-02-01 Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis1013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77550]], camposKey:0014-2565 2019-01-01 Tratamiento diurético del paciente con diabetes e insuficiencia cardiaca. El papel de los inhibidores de la SGLT2 y semejanzas con los inhibidores de la anhidrasa carbónica208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53649]], camposKey:0021-9150 2019-01-01 VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia1722, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77355]], camposKey:1931-857X 2018-11-01 Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77356]], camposKey:1933-2874 2018-08-01 Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study948957, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77468]], camposKey:0953-6205 2018-06-01 Use of degludec insulin in chronic complex patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77358]], camposKey:1081-5589 2018-02-01 Reply to "Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes' by Yoshimoto et al.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77357]], camposKey:1388-9842 2018-02-01 The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors409409, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77359]], camposKey:0025-7753 2018-01-12 Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?3338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77555]], camposKey:0025-7753 2018-01-01 Actualización del concepto del bloqueo dual del sistema renina-angiotensina-aldosterona. ¿Una nueva opción terapéutica?3338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77553]], camposKey:2530-0792 2018-01-01 Diabetes tipo 2 bien contralada y microalbuinuria2426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77361]], camposKey:0021-9150 2017-08-01 CARDIOVASCULAR RISK IN HIV-INFECTED WOMEN00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77360]], camposKey:0021-9150 2017-08-01 FAMILIAL HYPERCHOLESTEROLEMIA AND THE DIABETOGENIC EFFECT OF STATINS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77362]], camposKey:2092-6715 2017-07-01 I Can Not Wear My Sunglasses: An Unusual Sarcoidosis Presentation226228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77363]], camposKey:0009-7322 2017-05-30 Predicting Cardiovascular Events in Familial Hypercholesterolemia The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)21330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77365]], camposKey:1079-5642 2016-09-01 Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)20042010, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77366]], camposKey:1933-2874 2016-08-01 Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry953961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77364]], camposKey:0195-668X 2016-08-01 Do we reach the LDL-c goals in Familial hypercholesterolemiapatients under Eighteen Years Old? SAFEHEART (Spanish Familial Hypercholesterolemia Longitudinal Cohort Study) follow-up study10131013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77367]], camposKey:0735-1097 2016-03-22 Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up12781285, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77368]], camposKey:1738-6586 2016-01-01 Neurological Involvement in Erdheim-Chester Disease115116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77369]], camposKey:1046-6673 2015-08-01 Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3 '-Untranslated Region Polymorphism C+87T by MicroRNA-10718161825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77371]], camposKey:0735-1097 2014-04-22 Genetic Implication of a Novel Thiamine Transporter in Human Hypertension15421555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77372]], camposKey:0022-3042 2014-04-01 Chromogranin B: intra-and extra-cellular mechanisms to regulate catecholamine storage and release, in the catecholaminergic cells and organisms4859, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77370]], camposKey:0892-6638 2014-04-01 Regulation of chromogranin A by hsa-miR-107 in hypertension and nephropathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77373]], camposKey:0022-3042 2013-12-01 Genetic variation at the delta-sarcoglycan (SGCD) locus elevates heritable sympathetic nerve activity in human twin pairs750761, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77374]], camposKey:0964-6906 2013-09-15 MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension36243640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77375]], camposKey:0014-2565 2013-01-01 Being a physician ... "and initiate a post doctorate stay in the USA"6265, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77376]], camposKey:0263-6352 2013-01-01 Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y-2 receptor promoter disrupt multiple transcriptional response motifs123133, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77554]], camposKey:0014-2565 2013-01-01 Ser médico... "e iniciar una estancia posdoctoral en Estados Unidos"6265, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77377]], camposKey:0735-1097 2012-11-20 Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses (vol 60, pg 1678, 2012)22612261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77378]], camposKey:0735-1097 2012-10-23 Neuropeptide Y (NPY) Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses16781689, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77469]], camposKey:0025-7753 2012-03-03 Four-month history of weakness of lower limbs in a 50-years-old male Debilidad de miembros inferiores de cuatro meses de evolución en un varón de 50 años00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77537]], camposKey:0025-7753 2012-01-01 Debilidad de miembros inferiores de cuatro meses de evolución en un varón de 50 años2300, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77470]], camposKey:0025-7753 2011-11-12 Dyspnea of one-month duration in a 62 years-old woman Disnea de un mes de evolución en una mujer de 62 años00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77546]], camposKey:0214-8986 2011-01-01 Destrucción del carpo secundaria a gota sin tratamiento1480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77543]], camposKey:0025-7753 2011-01-01 Disnea de un mes de evolución en una mujer de 62 años5740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77548]], camposKey:0214-8986 2010-01-01 Anemia hemolítica inducida por amoxicilina-clavulánico566567, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77538]], camposKey:1137-6627 2010-01-01 Endocarditis secundaria a cateter de derivación ventriculo-atrial9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77379]], camposKey:1137-6627 2010-01-01 Secondary endocarditis to ventriculo-atrial shunt9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77471]], camposKey:1137-6627 2010-01-01 Secondary endocarditis to ventriculo-atrial shunt Endocarditis secundaria a catéter de derivación ventrículo-atrial9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77472]], camposKey:0014-2565 2009-05-01 Pleural effusion and arthralgias in relation to very advanced rheumatoid arthritis Derrame pleural y artralgias en relación con artritis reumatoide muy evolucionada250251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77473]], camposKey:1130-0108 2009-01-01 Abdominal pain for 9 days Dolor abdominal de 9 días de evolución424426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77552]], camposKey:0014-2565 2009-01-01 Derrame pleural y artralgias en relación con artritis reumatoide muy evolucionada250251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77535]], camposKey:0025-7753 2009-01-01 Síndrome de watermelon6480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77336]], camposKey:0014-2565 2008-06-01 Wallemberg's syndrome in patient without vascular risk factors319320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77539]], camposKey:0304-5412 2008-01-01 Hipoglucemia en pacientes diabéticos tipo 212041207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77474]], camposKey:0304-5412 2008-01-01 Hypoglycemia in type 2 diabetic patients Hipoglucemia en pacientes diabéticos tipo 212041207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77549]], camposKey:0304-5412 2008-01-01 Protocolo diagnóstico de la hiperglucemia en el embarazo y tratamiento de la diabetes gestacional11521157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77542]], camposKey:0304-5412 2008-01-01 Protocolo terapéutico de la hipoglucemia12171218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77475]], camposKey:0304-5412 2008-01-01 Therapeutic protocol for hypoglycemia Protocolo terapéutico de la hipoglucemia12171218][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30909]},camposKey: 138 0 Utilidad de los Hilos en Twitter para mejorar las habilidades para lalectura del electrocardiograma en estudiantes de medicina: TwittUVA-ECG, estudio cuasi-experimental comparando antes-después de la intervención 978-84-18321-43-6Actas del Congreso Internacional Virtual USATIC 2022, Ubicuo y Social: Aprendizaje con TIC 1 2022-01-01 Servicio de Publicaciones ][][][][][][][][][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7a00f3bd][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3241], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1c54]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1789b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1784c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16f19, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16cbc][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33720]},camposKey: El internista ante el desafío diagnóstico de la enfermedad de Castleman 978-84-18866-75-3Casos Clínicos del 42º Congreso Nacional de la Sociedad Española de Medicina Interna (SEMI) 1 2021-01-01 CTO Editorial, SL]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (109)

Tamayo-Velasco A.; Lopez-Herrero R.; Gomez-Garcia L.M.; Sanchez-de Prada L.; Aguilar-Monserrate G.; Martin-Fernandez M.; Bardaji-Carrillo M.; Alvaro-Meca A.; Tamayo E.; Resino S.; Miramontes-Gonzalez J.P.; Peñarrubia-Ponce M.J. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study . Journal of Infection and Public Health 2024; 17(6): 939-946

Enlace a la publicación
Ver Todos

Capítulos de libros (1)

Corral Gudino, Luis; Lopez Pardo, Alvaro; Miramontes Gonzalez, Jose Pablo; Martin Escudero, Juan Carlos; Perez Castrillon, Jose Luis; Dueñas Laita, Antonio. Utilidad de los Hilos en Twitter para mejorar las habilidades para lalectura del electrocardiograma en estudiantes de medicina: TwittUVA-ECG, estudio cuasi-experimental comparando antes-después de la intervención . En: -. Actas del Congreso Internacional Virtual USATIC 2022, Ubicuo y Social: Aprendizaje con TIC. Servicio de Publicaciones 2022. p. 138-0


Ver Todos

Actas de congresos (1)

Sanz Espinosa, P; Prieto Dehesa, M; Hernández Gómez, LM; Rey Hernández, M; Vargas Parra, D; Gabella Martín, M; Miramontes González, JP; Briongos Figuero, LS (2021). El internista ante el desafío diagnóstico de la enfermedad de Castleman. En VV.AA. Casos Clínicos del 42º Congreso Nacional de la Sociedad Española de Medicina Interna (SEMI). 1 ed. CTO Editorial, SL; 2021

Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (2)

ESTUDIO PAGETIOLOGÍA. ESTUDIO SOBRE LA ETIOLOGÍA DE LA ENFERMEDAD ÓSEA DE PAGET (EOP) EN CASTILLA Y LEÓN. Equipo Investigadores: CORRAL GUDINO, LUIS (IP); USATEGUI MARTIN, RICARDO; MIRAMONTES GONZALEZ, JOSE PABLO. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: FUNDACIÓN ESPAÑOLA DE INVESTIGACIÓN ÓSEA Y DEL METABOLISMO MINERAL (FEIOMM). 08/11/2024-07/11/2026

Ver Todos
 

OTROS

Congresos (1)

44 Congreso Nacional SEMI, Valencia ( ESPAÑA ) 15/11/2023 - 17/11/2023
(Comunicación). 79. Briongos Figuero LS, Mayo Íscar A, Gabella Martín M, Miramontes González JP, Pastor Mancisidor L, Morejón Huerta B, Abadía Otero J, Martín Escudero JC. Impacto de la docencia en Bioética en la Actitud frente a la Inteligencia Artificial en nuestros futuros profesionales
Ver Todos

Proyectos de innovación docente (4)

Semiología en imágenes - PID2023/37. Universidad de Valladolid. 01/09/2023.
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados